A prescribed drug to treat high blood pressure has shown promise against conditions such as Parkinson's, Huntington's and forms of dementia in studies carried out in mice and zebrafish at the University of Cambridge.
Apr 18, 2019
0
475
In the largest study of its kind to date, Cambridge researchers have looked at why some people manage to stay thin while others gain weight easily. They have found that the genetic dice are loaded in favour of thin people ...
Jan 24, 2019
1
623
Hip-hop artists Tupac and Eminem are among the most iconic music artists of the past two decades, and as Dr Akeem Sule and Dr Becky Inkster, co-founders of HIP-HOP-PSYCH, write, their lyrics can provide a valuable insight ...
Apr 12, 2016
1
42
(Medical Xpress) -- A new study has found that protein and not sugar activates the cells responsible for keeping us awake and burning calories. The research, published in the 17 November issue of the scientific journal Neuron, ...
Nov 16, 2011
2
0
Fathers as well as mothers can experience post-natal depression—and it is linked to emotional problems for their teenage daughters, new research has found.
Dec 26, 2018
0
114
Over-activity in a single brain region called the subgenual anterior cingulate cortex (sgACC) underlies several key symptoms of mood and anxiety disorders, but an antidepressant only successfully treats some of the symptoms. ...
Oct 26, 2020
0
284
Problems with iron levels in the blood and the body's ability to regulate this important nutrient as a result of SARS-CoV-2 infection could be a key trigger for long COVID, new research has discovered.
Mar 4, 2024
0
214
An artificial pancreas given to children and adults with type 1 diabetes going about their daily lives has been proven to work for 12 weeks – meaning the technology, developed at the University of Cambridge, can now offer ...
Sep 18, 2015
0
22
Addenbrooke's Hospital in Cambridge and 20 other hospitals from across the world and healthcare technology leader NVIDIA have used artificial intelligence (AI) to predict COVID patients' oxygen needs on a global scale.
Sep 15, 2021
0
215
A molecular chaperone has been found to inhibit a key stage in the development of Alzheimer's disease and break the toxic chain reaction that leads to the death of brain cells, a new study shows. The research provides an ...
Feb 17, 2015
1
308
